Clinical Trial Update: Anifrolumab Pregnancy Study

View source ↗

Summary

This document reports a planned clinical trial to evaluate pregnancy outcomes in people with systemic lupus erythematosus treated with anifrolumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SAPHNELO (ANIFROLUMAB-FNIA)

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING